Skip to content

To see the effect of 2 medicines namely Dashmoola Amritadi Kwatha and Shallaki Guggulu in the treatment of disease Amavata(Rheumatoid Arthritis)

add on effect of Dashmoola Amritadi Kwatha over Shallaki Guggulu(Shallaki Resin) in the management of Amavata w.s.r to Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021115
Enrollment
60
Registered
2019-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Shallaki Guggulu (Shallaki Resin): Oral administration of Shallaki Guggulu (Shallaki Resin) 1 gm, Before Meal, thrice/day Intervention2: Dashmoola Amritadi Kwath: Oral administration o

Sponsors

Ayurvedic and Unani Tibbia College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for trial. 2.patients will be selected randomly irrespective of sex, occupation and socio-economic status. 3.Patients suffering from disease since at least 1 years. 4.Subjects having classical features of Amavata like Angamarda, Aruchi,Trishna, Hrillasa, Alasya, Gaurava, Jwara, Shoola, Shotha. 5.The patients should fulfil the 2010 ACR(American College of Rheumatology) EULAR (European League Against Rheumatism Criteria) criteria for rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: Patients having Chronicity of more than 10 yrs. 2.Patients having Severe crippling bone deformity. 3.Patients having associated Cardiac disease, pulmonary tuberculosis and pregnant women and lactating mother. 4.patients having another type of arthropathy such as neoplasm of spine, gout, ankylosing spondylitis etc. 5.Juvenile rheumatoid arthritis. 6.Severely deformed joints. 7.Age below 30 and above 60.

Design outcomes

Primary

MeasureTime frame
Response in PainTimepoint: Followup at 15 days interval

Secondary

MeasureTime frame
Overall improvement in Quality of Life of patientsTimepoint: Follow up at 15 days interval

Countries

India

Contacts

Public ContactDR H C GUPTA

Ayurvedic and Unani Tibbia College, Karol Bagh, Delhi

hcgupta.dr@gmail.com9868909168

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026